Youcare Pharmaceutical Group Co., Ltd. (SHA:688658)
China flag China · Delayed Price · Currency is CNY
11.64
0.00 (0.00%)
Nov 6, 2026, 10:15 AM CST

SHA:688658 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2,3622,4463,7814,1964,5424,966
Revenue Growth
-7.29%-35.30%-9.90%-7.61%-8.53%14.45%
Gross Profit
1,2431,1882,1412,5742,8733,410
Operating Income
-239.84-235.77213.69214.88240574.2
Net Income
-318.22-262.39123.72184.8335.18545.32
Earnings Per Share
-0.72-0.590.280.410.741.21
EPS Growth
---31.71%-44.59%-38.84%-1.63%

Revenue by Segment

Fiscal Year
FY 2025
Period EndingDec '25
Anti-Infective
589.49
Cardiovascular
1,062
Digestive System
209.84
Hypoglycemic
179.68
Active Pharmaceutical Ingredient (API)
212.15
Technical Services
2.09
Other
184.53
Total
2,440

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,2701,4201,4931,4831,6612,437
Total Debt
679.47608.15705.31462.91277.7537.55
Net Cash (Debt)
590.13811.7787.861,0201,3842,400
Net Cash Growth
-13.85%3.03%-22.73%-26.31%-42.34%2.81%
Net Cash Per Share
1.341.831.782.263.055.32

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
88.96340.29438.24785.49-121.17515.24
Capital Expenditures
-104.22-135.08-358.6-497.48-547.96-200.49
Free Cash Flow
-15.26205.2179.64288.01-669.13314.75
Free Cash Flow Growth
-157.67%-72.35%---44.87%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
52.64%48.58%56.62%61.35%63.25%68.67%
Operating Margin
-10.15%-9.64%5.65%5.12%5.28%11.56%
Pretax Margin
-12.14%-9.69%4.03%5.32%7.70%12.67%
Profit Margin
-13.47%-10.73%3.27%4.40%7.38%10.98%
FCF Margin
-0.65%8.39%2.11%6.86%-14.73%6.34%

Dividends

Fiscal Year
FY 2023FY 2022FY 2021
Period EndingDec '23 Dec '22 Dec '21
Dividend Per Share
0.2001.1000.680
Dividend Per Share Growth
-81.82%61.77%51.11%
Dividend Yield
0.95%5.69%2.29%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--51.7750.8025.9424.52
Forward PE
-161.5017.00---
P/FCF Ratio
-48.9780.4332.59-42.48
PS Ratio
2.194.111.692.241.912.69